Drugs / 2-Fluoro-2-deoxyglucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001568 | Feb 1997 → Oct 2002 | colorectal neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-Fluoro-2-deoxyglucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001568 ↗ |
| Route | Intravenous | “Fludeoxyglucose F 18 (FDG) is injected intravenously over 2 min.” NCT00001568 ↗ |